+499.5%
MRNA vs AMCR
+13.1%
+486.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AMCR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.2% | -2.0% | -2.0% |
| 7D | +5.5% | -1.9% | +7.3% | +7.2% |
| 30D | +158.7% | -4.1% | +162.8% | +166.8% |
| 3M | +182.1% | +21.7% | +160.5% | +170.2% |
| 6M | +151.8% | +1.5% | +150.3% | +146.6% |
| YTD | +393.6% | +13.1% | +380.4% | +370.1% |
| 1Y | +499.5% | +13.0% | +486.5% | +515.4% |
| All | +499.5% | +13.1% | +486.3% | +515.4% |
Cumulative growth
Daily Returns
Daily percentage return beside AMCR.
Daily Out/Under-Performance
Portfolio return minus AMCR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMCR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AMCR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling